Cargando…

Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options

Anti-vascular endothelial growth factor (anti-VEGF) therapy currently plays a central role in the treatment of numerous retinal diseases, most notably exudative age-related macular degeneration (eAMD), diabetic retinopathy and retinal vein occlusions. While offering significant functional and anatom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wallsh, Josh O., Gallemore, Ron P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145407/ https://www.ncbi.nlm.nih.gov/pubmed/33946803 http://dx.doi.org/10.3390/cells10051049

Ejemplares similares

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy
por: Wallsh, Josh, et al.
Publicado: (2016)

Identifying rhegmatogenous detachments in bullous retinoschisis with optical coherence tomography studies
por: Wallsh, Josh O, et al.
Publicado: (2016)

Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review
por: Wallsh, Josh, et al.
Publicado: (2020)

Outcomes of Epiretinal Membrane Removal Utilizing Triamcinolone Acetonide Visualization and Internal Limiting Membrane Forceps
por: Asahi, Masumi G, et al.
Publicado: (2020)

Long-Term Outcomes of Macular Hole Repair with Triamcinolone Acetonide Visualization
por: Wallsh, Josh, et al.
Publicado: (2021)

Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study
por: Asahi, Masumi G, et al.
Publicado: (2020)

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial
por: Gallemore, Ron P, et al.
Publicado: (2017)

Latest developments and emerging treatment options in the management of stomach cancer
por: Delaunoit, Thierry
Publicado: (2011)

Renal Denervation for Resistant Hypertension: A Concise Update on Treatment Options and the Latest Clinical Evidence
por: Fengler, Karl
Publicado: (2022)

Carbapenem-Resistant Klebsiella pneumoniae: Virulence Factors, Molecular Epidemiology and Latest Updates in Treatment Options
por: Karampatakis, Theodoros, et al.
Publicado: (2023)

Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases
por: Seah, Ivan, et al.
Publicado: (2020)

Latest Treatment Option and Technology Advancement in Corneal and Ocular Surface Disease
por: Costagliola, Ciro, et al.
Publicado: (2014)

Case Report on Giant Pars Plana Cysts Mimicking Retinal Detachment
por: Braceros, Kathryn Kelani, et al.
Publicado: (2020)

Anti-VEGF treatment and peripheral retinal nonperfusion in patients with central retinal vein occlusion
por: Abri Aghdam, Kaveh, et al.
Publicado: (2017)

Review of effects of anti-VEGF treatment on refractive error
por: Mintz-Hittner, Helen A, et al.
Publicado: (2016)

Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates: Revolutions in treatment options in GIST
por: Farag, Sheima, et al.
Publicado: (2020)

Vitamin A Derivatives as Treatment Options for Retinal Degenerative Diseases
por: Perusek, Lindsay, et al.
Publicado: (2013)

The Latest Option: Nivolumab and Relatlimab in Advanced Melanoma
por: Albrecht, Lea Jessica, et al.
Publicado: (2023)

Latest Innovations in the Treatment of Venous Disease
por: Attaran, Robert R.
Publicado: (2018)

Progress and Challenges of Anti-VEGF Agents and Their Sustained-Release Strategies for Retinal Angiogenesis
por: Xu, Manhong, et al.
Publicado: (2022)

Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy
por: Asahi, Masumi G, et al.
Publicado: (2017)

Understanding patient preferences in anti-VEGF treatment options for age-related macular degeneration
por: Ozdemir, Semra, et al.
Publicado: (2022)

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
por: Levin, Ariana M, et al.
Publicado: (2017)

Combined Central Retinal Artery and Vein Occlusion with Ischemic Optic Neuropathy After COVID-19 Vaccination
por: Lee, Sol, et al.
Publicado: (2022)

Retinal vein occlusion: pathophysiology and treatment options
por: Karia, Niral
Publicado: (2010)

Mechanisms of Acquired Resistance to Anti-VEGF Therapy for Neovascular Eye Diseases
por: Sharma, Dhyana, et al.
Publicado: (2023)

Curcumin as a Therapeutic Option in Retinal Diseases
por: López-Malo, Daniel, et al.
Publicado: (2020)

Commentary: The latest in retinal surgical instruments
por: Venkatesh, Ramesh, et al.
Publicado: (2022)

Outer retinal tubulation in diabetic macular edema following anti-VEGF treatment
por: Al-Halafi, Ali M
Publicado: (2015)

Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
por: Itatani, Yoshiro, et al.
Publicado: (2018)

Topical difluprednate for the treatment of Harada’s disease
por: Onishi, Spencer M, et al.
Publicado: (2015)

Vitamins in Alzheimer’s Disease—Review of the Latest Reports
por: Mielech, Anita, et al.
Publicado: (2020)

Correction: Use of biomaterials for sustained delivery for anti-VEGF to treat retinal diseases
por: Seah, Ivan, et al.
Publicado: (2020)

Gene profiling of human VEGF signaling pathways in human endothelial and retinal pigment epithelial cells after anti VEGF treatment
por: Golan, Shani, et al.
Publicado: (2014)

Mature vessel occlusion after anti-VEGF treatment in a retinal arteriovenous malformation
por: Chuang, Lan-Hsin, et al.
Publicado: (2013)

Safety of anti-VEGF treatments in a diabetic rat model and retinal cell culture
por: Filek, Richard, et al.
Publicado: (2019)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

Anti-VEGF Treatment Strategies for Wet AMD
por: Kovach, Jaclyn L., et al.
Publicado: (2012)

An experimental study of VEGF induced changes in vasoactivity in pig retinal arterioles and the influence of an anti-VEGF agent
por: Su, Er-Ning, et al.
Publicado: (2012)

Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients
por: Ria, Roberto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i65et0sgkrrm8mqa73glf0k5c7